Literature DB >> 1638030

Spectrin Jendouba: an alpha II/31 spectrin variant that is associated with elliptocytosis and carries a mutation distant from the dimer self-association site.

N Alloisio1, R Wilmotte, L Morlé, F Baklouti, J Maréchal, M T Ducluzeau, L Denoroy, C Féo, B G Forget, R Kastally.   

Abstract

Spectrin Jendouba (alpha II/31) was found in a Tunisian family. In the heterozygous state, it is associated with asymptomatic elliptocytosis and a minimal defect in spectrin dimer self-association. On partial digestion of spectrin with trypsin, an abnormal cleavage appeared following Lys 788. Peptide and DNA sequencing indicated that the responsible mutation is alpha 791 Asp----Glu (GAC----GAA). As in most alpha-spectrin variants associated with elliptocytosis, the change alters helix 3 of the proposed triple helical model of spectrin structure. Modified helix 3 in repeat alpha 8 is the most distant from the N-terminus of alpha-spectrin in known variants associated with elliptocytosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46.

Authors:  R Wilmotte; J Maréchal; L Morlé; F Baklouti; N Philippe; R Kastally; L Kotula; J Delaunay; N Alloisio
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.

Authors:  Omar Niss; Satheesh Chonat; Neha Dagaonkar; Marya O Almansoori; Karol Kerr; Zora R Rogers; Patrick T McGann; Maa-Ohui Quarmyne; Mary Risinger; Kejian Zhang; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2016-07-17       Impact factor: 3.039

3.  Understanding pathogenic single-nucleotide polymorphisms in multidomain proteins--studies of isolated domains are not enough.

Authors:  Lucy G Randles; Gwen J S Dawes; Beth G Wensley; Annette Steward; Adrian A Nickson; Jane Clarke
Journal:  FEBS J       Date:  2013-01-16       Impact factor: 5.542

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.